Clinical Trial Update: Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating obatoclax mesylate with carboplatin and etoposide versus carboplatin and etoposide alone in chemotherapy-naive patients with extensiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Obatoclax Mesylate (obatoclax mesylate)

Snippet

Sponsor: Cephalon | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 3 | Status: WITHDRAWN